Universal Ibogaine Inc. (IBOGF)
OTCMKTS · Delayed Price · Currency is USD
0.0182
-0.0002 (-1.09%)
Jul 17, 2025, 3:17 PM EDT
Universal Ibogaine Market Cap
Universal Ibogaine has a market cap or net worth of $5.61 million as of July 17, 2025. Its market cap has increased by 754.42% in one year.
Market Cap
5.61M
Enterprise Value
7.39M
Revenue
1.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since October 5, 2021, Universal Ibogaine's market cap has decreased from 27.27M to 5.61M, a decrease of -79.42%. That is a compound annual growth rate of -34.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2025 | 5.61M | 423.31% |
| Dec 31, 2024 | 1.07M | 47.59% |
| Dec 28, 2023 | 726.62K | -65.76% |
| Dec 30, 2022 | 2.12M | -88.73% |
| Dec 31, 2021 | 18.82M | -30.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.59B |
| Veradigm | 857.64M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 575.00M |
| Glass House Brands | 456.35M |
| CytoDyn | 399.02M |
| Northwest Biotherapeutics | 386.53M |